Literature DB >> 2577866

Identification of a transforming activity suppressing sequence in the c-raf oncogene.

F Ishikawa1, R Sakai, M Ochiai, F Takaku, T Sugimura, M Nagao.   

Abstract

Our previous study revealed that the rat c-raf was activated by a rearrangement leading to replacement of the amino-terminal half of the product. Therefore, we suggested that some sequences present in the amino-terminal half might prevent c-raf from becoming an active oncogene. To examine this possibility, we constructed a series of deletion mutants of c-raf cDNA by the random linker insertion method. By transfection of NIH3T3 cells with these mutants, a region whose deletion resulted in activation of c-raf was identified. This region is located at amino acid residues 245 to 261, immediate upstream of the kinase domain of the c-raf product and is rich in serine and threonine residues. This region includes a sequence of six amino acids, RSTSTP, which is conserved in the products of normal raf gene families of various species. This sequence is the best candidate for suppressing transforming activity of c-raf.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2577866

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Common mechanism of retrovirus activation and transduction of c-mil and c-Rmil in chicken neuroretina cells infected with Rous-associated virus type 1.

Authors:  M P Felder; A Eychène; J V Barnier; I Calogeraki; G Calothy; M Marx
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 2.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

3.  Raf-1 N-terminal sequences necessary for Ras-Raf interaction and signal transduction.

Authors:  K Pumiglia; Y H Chow; J Fabian; D Morrison; S Decker; R Jove
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

4.  The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site.

Authors:  H R Mott; J W Carpenter; S Zhong; S Ghosh; R M Bell; S L Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  Mutational activation of c-raf-1 and definition of the minimal transforming sequence.

Authors:  G Heidecker; M Huleihel; J L Cleveland; W Kolch; T W Beck; P Lloyd; T Pawson; U R Rapp
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

Review 6.  Raf kinases: function, regulation and role in human cancer.

Authors:  Deborah T Leicht; Vitaly Balan; Alexander Kaplun; Vinita Singh-Gupta; Ludmila Kaplun; Melissa Dobson; Guri Tzivion
Journal:  Biochim Biophys Acta       Date:  2007-05-22

7.  Flat reversion by okadaic acid of raf and ret-II transformants.

Authors:  R Sakai; I Ikeda; H Kitani; H Fujiki; F Takaku; U Rapp; T Sugimura; M Nagao
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 8.  Signal transduction pathways involving the Raf proto-oncogene.

Authors:  N G Williams; T M Roberts
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

9.  MEK-1 activates C-Raf through a Ras-independent mechanism.

Authors:  Deborah T Leicht; Vitaly Balan; Jun Zhu; Alexander Kaplun; Agnieszka Bronisz; Ajay Rana; Guri Tzivion
Journal:  Biochim Biophys Acta       Date:  2013-01-27

Review 10.  Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention.

Authors:  Ruth Nussinov; Mingzhen Zhang; Chung-Jung Tsai; Tsung-Jen Liao; David Fushman; Hyunbum Jang
Journal:  Biophys Rev       Date:  2018-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.